Concord Biotech gets GMP for unit II of Gujarat facility

23 Feb 2024 Evaluate

Ministry of Health Pharmacy and Poisons Board, Republic of Kenya has completed inspection at Concord Biotech’s Unit II (formulation facility), located at Valthera-Dholka in Ahmedabad, Gujarat. The said inspection has been completed successfully, without any adverse remarks and the company has received the certificate of Good manufacturing practices (GMP) as on February 22, 2024. 

The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series and other internationally acceptable guidelines. 

Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.

Concord Biotech Share Price

1404.05 1.00 (0.07%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×